New research reveals that ER+ breast cancer cells acquire aggressive characteristics through direct contact with bone marrow ...

Fred Hutch grew from a regional cancer center into a world-class biomedical research and clinical care institution known for ...

In a personal essay for PEOPLE, TikTok star Eldiara Doucette opens up about her recurring soft tissue cancer, losing her ...

Tumor Infiltrating Lymphocytes (TIL) is under clinical development by Essen Biotech and currently in Phase II for Metastatic Breast Cancer.

The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...

A young father - and die-hard Buffalo Bills fan - is facing the fight of his life after being diagnosed with a rare cancer.

The newly approved methastatic Renal Cell Cancer (mRCC) Phase 1/2a trial began in Q4 2024, and Genenta expects to treat six patients by the end of the first half of 2025, while continuing progress ...

Researchers developed and validated a nomogram to predict 1-, 2-, and 3-year overall survival (OS) in patients with ovarian ...

A pioneering study has uncovered the complex and dual roles of neutrophils in cancer development, demonstrating their ...

Machine learning doesn’t replace humans. But AI does assist them in doing their job better by helping predict the success – ...

Recent advancements in medical technology have revolutionized limb-salvage surgery and functional reconstruction for pediatric bone and soft tissue tumors.

The FDA’s breakthrough therapy designation for GSK’227 underscores its potential to address the critical unmet needs of ...